A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.

AIMS/HYPOTHESIS: We identified a mouse with a point mutation (Y12STOP) in the Kcnj11 subunit of the K(ATP) channel. This point mutation is identical to that found in a patient with congenital hyperinsulinism of infancy (HI). We aimed to characterise the phenotype arising from this loss-of-function m...

Full description

Bibliographic Details
Main Authors: Hugill, A, Shimomura, K, Ashcroft, F, Cox, R
Format: Journal article
Language:English
Published: 2010
_version_ 1797079327135760384
author Hugill, A
Shimomura, K
Ashcroft, F
Cox, R
author_facet Hugill, A
Shimomura, K
Ashcroft, F
Cox, R
author_sort Hugill, A
collection OXFORD
description AIMS/HYPOTHESIS: We identified a mouse with a point mutation (Y12STOP) in the Kcnj11 subunit of the K(ATP) channel. This point mutation is identical to that found in a patient with congenital hyperinsulinism of infancy (HI). We aimed to characterise the phenotype arising from this loss-of-function mutation and to compare it with that of other mouse models and patients with HI. METHODS: We phenotyped an N-ethyl-N-nitrosourea-induced mutation on a C3H/HeH background (Kcnj11 ( Y12STOP )) using intraperitoneal glucose tolerance testing to measure glucose and insulin plasma concentrations. Insulin secretion and response to incretins were measured on isolated islets. RESULTS: Homozygous male and female adult Kcnj11 ( Y12STOP ) mice exhibited impaired glucose tolerance and a defect in insulin secretion as measured in vivo and in vitro. Islets had an impaired incretin response and reduced insulin content. CONCLUSIONS/INTERPRETATION: The phenotype of homozygous Kcnj11 ( Y12STOP ) mice is consistent with that of other Kcnj11-knockout mouse models. In contrast to the patient carrying this mutation homozygously, the mice studied did not have hyperinsulinaemia or hypoglycaemia. It has been reported that HI patients may develop diabetes and our mouse model may reflect this clinical feature. The Kcnj11 ( Y12STOP ) model may thus be useful in further studies of K(ATP) channel function in various cell types and in investigation of the development of hyperglycaemia in HI patients.
first_indexed 2024-03-07T00:44:16Z
format Journal article
id oxford-uuid:8413bb39-bbe7-4cc2-8b46-588a0ade83b6
institution University of Oxford
language English
last_indexed 2024-03-07T00:44:16Z
publishDate 2010
record_format dspace
spelling oxford-uuid:8413bb39-bbe7-4cc2-8b46-588a0ade83b62022-03-26T21:48:47ZA mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8413bb39-bbe7-4cc2-8b46-588a0ade83b6EnglishSymplectic Elements at Oxford2010Hugill, AShimomura, KAshcroft, FCox, RAIMS/HYPOTHESIS: We identified a mouse with a point mutation (Y12STOP) in the Kcnj11 subunit of the K(ATP) channel. This point mutation is identical to that found in a patient with congenital hyperinsulinism of infancy (HI). We aimed to characterise the phenotype arising from this loss-of-function mutation and to compare it with that of other mouse models and patients with HI. METHODS: We phenotyped an N-ethyl-N-nitrosourea-induced mutation on a C3H/HeH background (Kcnj11 ( Y12STOP )) using intraperitoneal glucose tolerance testing to measure glucose and insulin plasma concentrations. Insulin secretion and response to incretins were measured on isolated islets. RESULTS: Homozygous male and female adult Kcnj11 ( Y12STOP ) mice exhibited impaired glucose tolerance and a defect in insulin secretion as measured in vivo and in vitro. Islets had an impaired incretin response and reduced insulin content. CONCLUSIONS/INTERPRETATION: The phenotype of homozygous Kcnj11 ( Y12STOP ) mice is consistent with that of other Kcnj11-knockout mouse models. In contrast to the patient carrying this mutation homozygously, the mice studied did not have hyperinsulinaemia or hypoglycaemia. It has been reported that HI patients may develop diabetes and our mouse model may reflect this clinical feature. The Kcnj11 ( Y12STOP ) model may thus be useful in further studies of K(ATP) channel function in various cell types and in investigation of the development of hyperglycaemia in HI patients.
spellingShingle Hugill, A
Shimomura, K
Ashcroft, F
Cox, R
A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
title A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
title_full A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
title_fullStr A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
title_full_unstemmed A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
title_short A mutation in KCNJ11 causing human hyperinsulinism (Y12X) results in a glucose-intolerant phenotype in the mouse.
title_sort mutation in kcnj11 causing human hyperinsulinism y12x results in a glucose intolerant phenotype in the mouse
work_keys_str_mv AT hugilla amutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT shimomurak amutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT ashcroftf amutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT coxr amutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT hugilla mutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT shimomurak mutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT ashcroftf mutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse
AT coxr mutationinkcnj11causinghumanhyperinsulinismy12xresultsinaglucoseintolerantphenotypeinthemouse